PYPD
Price
$3.45
Change
+$0.05 (+1.47%)
Updated
Sep 5 closing price
Capitalization
54.85M
58 days until earnings call
SPHRF
Price
$0.10
Change
+$0.02 (+25.00%)
Updated
Aug 26 closing price
Capitalization
35.46M
Interact to see
Advertisement

PYPD vs SPHRF

Header iconPYPD vs SPHRF Comparison
Open Charts PYPD vs SPHRFBanner chart's image
PolyPid
Price$3.45
Change+$0.05 (+1.47%)
Volume$24.88K
Capitalization54.85M
Starpharma Holdings
Price$0.10
Change+$0.02 (+25.00%)
Volume$23.82K
Capitalization35.46M
PYPD vs SPHRF Comparison Chart in %
Loading...
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PYPD vs. SPHRF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYPD is a StrongBuy and SPHRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (PYPD: $3.45 vs. SPHRF: $0.10)
Brand notoriety: PYPD and SPHRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PYPD: 28% vs. SPHRF: 116%
Market capitalization -- PYPD: $54.85M vs. SPHRF: $35.46M
PYPD [@Biotechnology] is valued at $54.85M. SPHRF’s [@Biotechnology] market capitalization is $35.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PYPD’s FA Score shows that 1 FA rating(s) are green whileSPHRF’s FA Score has 0 green FA rating(s).

  • PYPD’s FA Score: 1 green, 4 red.
  • SPHRF’s FA Score: 0 green, 5 red.
According to our system of comparison, PYPD is a better buy in the long-term than SPHRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PYPD’s TA Score shows that 4 TA indicator(s) are bullish while SPHRF’s TA Score has 5 bullish TA indicator(s).

  • PYPD’s TA Score: 4 bullish, 4 bearish.
  • SPHRF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SPHRF is a better buy in the short-term than PYPD.

Price Growth

PYPD (@Biotechnology) experienced а +2.99% price change this week, while SPHRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PYPD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYPD($54.8M) has a higher market cap than SPHRF($35.5M). SPHRF YTD gains are higher at: 33.970 vs. PYPD (13.487). SPHRF has higher annual earnings (EBITDA): -13.7M vs. PYPD (-33.1M). SPHRF has higher revenues than PYPD: SPHRF (2.98M) vs PYPD (0).
PYPDSPHRFPYPD / SPHRF
Capitalization54.8M35.5M154%
EBITDA-33.1M-13.7M242%
Gain YTD13.48733.97040%
P/E RatioN/AN/A-
Revenue02.98M-
Total Cash29.5MN/A-
Total Debt8.67MN/A-
FUNDAMENTALS RATINGS
SPHRF: Fundamental Ratings
SPHRF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PYPDSPHRF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
76%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
37%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
35%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 27 days ago
43%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPHRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCFN49.540.54
+1.10%
Muncy Columbia Financial Corporation
IDGAF0.08N/A
N/A
5TH PLANET GAMES
CRTUF10.87N/A
N/A
Cartica Acquisition Corp.
EKIVY7.25N/A
N/A
Enka Insaat Ve Sanayi AS
DESLF358757760.00N/A
N/A
Descente, Ltd.

PYPD and

Correlation & Price change

A.I.dvisor tells us that PYPD and SER have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and SER's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYPD
1D Price
Change %
PYPD100%
+1.47%
SER - PYPD
27%
Poorly correlated
-3.60%
PRTA - PYPD
27%
Poorly correlated
+4.14%
SLGL - PYPD
26%
Poorly correlated
-0.14%
CING - PYPD
24%
Poorly correlated
+2.90%
ORIC - PYPD
24%
Poorly correlated
+1.02%
More

SPHRF and

Correlation & Price change

A.I.dvisor tells us that SPHRF and SYBX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRF and SYBX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRF
1D Price
Change %
SPHRF100%
N/A
SYBX - SPHRF
29%
Poorly correlated
N/A
SPHRY - SPHRF
26%
Poorly correlated
N/A
SOLTF - SPHRF
23%
Poorly correlated
N/A
RNXT - SPHRF
22%
Poorly correlated
+4.20%
PYPD - SPHRF
21%
Poorly correlated
+1.47%
More